ENZY — Enzymatica AB (publ) Balance Sheet
0.000.00%
Last trade - 00:00- SEK473.33m
- SEK429.63m
- SEK45.58m
Annual balance sheet for Enzymatica AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 24 | 31.6 | 50.7 | 8.37 | 75.2 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 35.8 | 18.8 | 16.5 | 13.5 | 14.3 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 10.3 | 15.2 | 16.4 | 16.5 | 14.4 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Other Assets | |||||
| Total Assets | 162 | 157 | 174 | 126 | 195 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 55.4 | 32.1 | 48.1 | 49.3 | 18.9 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 107 | 125 | 126 | 76.6 | 176 |
| Total Liabilities & Shareholders' Equity | 162 | 157 | 174 | 126 | 195 |
| Total Common Shares Outstanding |